DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized gene therapy aims to heal unhealable wounds
Disease control OngoingThis study is testing a personalized cell therapy called D-Fi to see if it helps heal stubborn wounds in people with dystrophic epidermolysis bullosa (DEB), a painful genetic condition that causes fragile, blistering skin. In the trial, each participant's own skin cells are genet…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New eye drops aim to soothe painful eye damage in 'Butterfly Skin' disease
Symptom relief OngoingThis study is testing whether a new eye drop called ELK-003 can help reduce painful eye problems in people with epidermolysis bullosa (EB), a condition that causes fragile skin and frequent corneal abrasions. For 6 months, 20 participants will use the drops 6 times daily to see i…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC